HiveProspectStranded Biotech Asset IntelligenceResearch intelligence
Research workspace tools

Sodium Valproate

TERMINATED · PHASE2, PHASE3 · Neuralgia, Neuropathic Peripheral Pain

slow recruitment and treatments beyond expiry date

Registry source

Scientific benefit, asset-specific safety, ownership and licensing: Unknown without reviewed evidence.

Detailed evidence is available in the local Pro plan simulation.